Ditchcarbon
  • Customers
  1. Organizations
  2. MiMedx Group, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 5 months ago

MiMedx Group, Inc.

Company website

MiMedx Group, Inc., a leading biotechnology firm headquartered in the United States, specialises in regenerative medicine and advanced wound care. Founded in 2008, the company has made significant strides in the industry, particularly in the development of placental tissue-based products that promote healing and tissue regeneration. With a strong presence across North America, MiMedx focuses on innovative solutions for chronic wounds and surgical applications. Its core offerings, including allografts and amniotic tissue products, are distinguished by their unique properties that enhance patient recovery. Recognised for its commitment to quality and efficacy, MiMedx has established a notable market position, contributing to advancements in healthcare and improving patient outcomes.

DitchCarbon Score

How does MiMedx Group, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

MiMedx Group, Inc.'s score of 25 is lower than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.

30%

Let us know if this data was useful to you

MiMedx Group, Inc.'s reported carbon emissions

MiMedx Group, Inc., headquartered in the US, currently does not have available carbon emissions data for the most recent year, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. As of now, MiMedx Group, Inc. does not inherit emissions data from any parent or related organisations, indicating that their climate commitments and emissions reporting are independent. Without specific emissions data or reduction initiatives, it is unclear how the company is addressing its carbon footprint or contributing to climate action within its industry. In the absence of concrete data, it is essential for MiMedx Group, Inc. to establish clear climate commitments and reduction targets to align with industry standards and expectations for sustainability.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. MiMedx Group, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for MiMedx Group, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

MiMedx Group, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

International Stem Cell Corporation

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

BioTissue Holdings Inc.

US
•
Research and development services (73)
Updated 13 days ago

DePuy Synthes, Inc.

US
•
Health and social work services (85)
Updated 13 days ago

Axogen

US
•
Other business services (74)
Updated about 20 hours ago

Vericel Corporation

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Compugen Ltd.

IL
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250808.1
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy